Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
ExpreS2ion Biotech Holding AB (5JD0)
Market Closed
12 Aug, 20:00
XFRA
All
(1)
DE
(1)
XFRA
Primary
0.
11
+0.01
+5.3398%
938.91K
Market Cap
-
P/E Ratio
-
Div Yield
2,687
Volume
0
Eps
0.1
Previous Close
Watching
Watch
Add Transaction
Day Range
0.11
0.11
Year Range
0.03
2.16
Want to track
5JD0
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
Historical Data
ExpreS2ion Biotech Holding AB (5JD0) Statistics
Valuation metrics
Market Cap
938.91K
Enterprise value
-
Trailing P/E (ttm)
0.01
Forward P/E
-
PEG ratio
-0
Price/Sales (ttm)
0.42
Price/Book (mrq)
0.01
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
-
Overview
Shares outstanding
9.88M
Float
2.55M
Shares short
-
% Held by insiders
0.01%
% Held by institutions
0%
Average volume (10 days)
62
Average volume (90 days)
92
Price summary
52-Week low
0.03
52-Week high
2.16
Beta
2.2
50-Day moving average
0.24
200-Day moving average
1.21
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
0.03:1
Last split Date
30 Oct 2024
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.04%
Operating margin
-11.96%
Operational effectiveness
Return on assets
-0.4%
Return on equity
-0.88%
Income Statement
Revenue (ttm)
3.66M
Revenue per share (ttm)
1.29
Quarterly revenue growth (yoy)
0.62%
Gross profit (ttm)
137K
EBITDA
-4.81M
Net income to common (ttm)
-38.09M
Diluted EPS (ttm)
-0.44
Quarterly earnings growth (yoy)
-0.27%
Balance Sheet
Total cash (mrq)
47.55M
Total cash per share (mrq)
5
Total debt (mrq)
-
Total Debt/Equity (mrq)
3.79
Current ratio (mrq)
1.98%
Book value per share (mrq)
12.52
Cash Flow
Cash flow statement
-51.41M
Levered free cash flow (LFCF)
-3.41M